Kymera Investor Presentation Deck

Adverse Events Related to Study Drug (Occurring in > 1 Patient) Adverse Event (Preferred Term) Headache KYMERA Fatigue Diarrhea # of Patients ©2023 KYMERA THERAPEUTICS, INC. 6 4 2 Severity (# of Pts) Mild (5) Severe (1) Mild (4) Mild (2) Outcome (# of Pts) Recovered (6) Recovered (4) No SAEs, no drug-related infections, and no AEs observed leading to dose interruption or discontinuation Recovered (2) PAGE 31

View entire presentation